Issued 2026-09-16 at $37.55 · now $37.55 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, CPF has typically landed between $33.35 and $42.78 — a range of −11.2% to +13.9% from the issuance price $37.55.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($37.55) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where CPF has typically landed a month from the 2026-09-16 close of $37.55 — the range is history, not a prediction.
- now $37.55 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $37.89 (+0.9%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $35.74–$40.04
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $33.35–$42.78
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2009-10-28 | −63.8% | −63.8% | +0.0% |
| 2009-10-19 | −60.7% | −60.7% | +0.4% |
| 2009-10-15 | −60.5% | −60.5% | +0.0% |
| 3 best | |||
| 2010-03-23 | +113.4% | +0.0% | +113.4% |
| 2008-08-20 | +101.7% | −2.3% | +101.7% |
| 2010-03-24 | +91.4% | −5.1% | +91.4% |
5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-12 | Ngo Agnes Catherine | director | Sale | 3,333 @ $30.66 | $102K | −5.2% of holding | −7.0% | −0.5% | 60,514 | Form 4 · filed same day |
| 2025-08-14 | KOSASA PAUL | director | Sale | 923 @ $28.63 | $26K | −100.0% of holding | +4.6% | +14.5% | 0 | Form 4 · filed 15 days after the trade |
| 2025-08-12 | Ngo Agnes Catherine | director | Sale | 3,333 @ $27.87 | $93K | −4.8% of holding | +8.9% | +15.0% | 65,459 | Form 4 · filed same day |
| 2025-08-01 | Yonamine Paul K | director | Sale | 2,765 @ $26.25 | $73K | −16.3% of holding | +16.3% | +15.9% | 14,181 | Form 4 · filed same day |
| 2025-07-14 | Ngo Agnes Catherine | director | Sale | 3,333 @ $29.20 | $97K | −4.6% of holding | −7.5% | −3.7% | 68,792 | Form 4 · filed same day |
| 2025-07-01 | Yonamine Paul K | director | Sale | 2,765 @ $28.00 | $77K | −14.0% of holding | −9.7% | +0.3% | 16,946 | Form 4 · filed same day |
| 2025-06-12 | Ngo Agnes Catherine | director | Sale | 3,333 @ $26.99 | $90K | −4.4% of holding | −0.3% | +5.5% | 72,125 | Form 4 · filed same day |
| 2025-06-05 | Yonamine Paul K | director | Sale | 2,765 @ $26.31 | $73K | −12.3% of holding | +7.0% | +2.4% | 19,711 | Form 4 · filed 1 day after the trade |
| 2025-05-12 | Ngo Agnes Catherine | director | Sale | 3,333 @ $27.71 | $92K | −4.4% of holding | −3.6% | −9.2% | 72,922 | Form 4 · filed same day |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
93 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-07 | Martines Arnold D | officer | Gift | 2,750 | 3,940 | Form 4 |
| 2026-05-15 | Nobriga Robert | director | Award / grant | 2,303 | 8,580 | Form 4 |
| 2026-05-15 | Kindred Jonathan B | director | Award / grant | 2,228 | 16,178 | Form 4 |
| 2026-05-15 | FRY EARL E | director | Award / grant | 2,117 | 12,999 | Form 4 |
| 2026-05-15 | Ota Saedene K | director | Award / grant | 2,117 | 15,931 | Form 4 |
| 2026-05-15 | Lutes Christopher | director | Award / grant | 2,080 | 23,684 | Form 4 |
| 2026-05-15 | Paloma Diane S.L. | director | Award / grant | 2,080 | 4,870 | Form 4 |
| 2026-05-15 | KOSASA PAUL | director | Award / grant | 1,857 | 74,569 | Form 4 |
| 2026-05-15 | Fujimoto Jason | director | Award / grant | 1,857 | 12,192 | Form 4 |
| 2026-05-15 | Rose Crystal | director | Award / grant | 1,857 | 16,882 | Form 4 |
| 2026-02-17 | Martines Arnold D | officer | Withheld for tax | 6,324 | 7,060 | Form 4 |
| 2026-02-17 | Morimoto David | officer | Withheld for tax | 3,371 | 4,375 | Form 4 |
| 2026-02-17 | Martines Arnold D | officer | Withheld for tax | 3,152 | 14,702 | Form 4 |
| 2026-02-17 | Martines Arnold D | officer | Withheld for tax | 2,109 | 8,398 | Form 4 |
| 2026-02-17 | Martines Arnold D | officer | Withheld for tax | 2,056 | 10,996 | Form 4 |
| 2026-02-17 | Morimoto David | officer | Withheld for tax | 1,319 | 9,623 | Form 4 |
| 2026-02-17 | Morimoto David | officer | Withheld for tax | 833 | 5,247 | Form 4 |
| 2026-02-17 | Morimoto David | officer | Withheld for tax | 713 | 5,918 | Form 4 |
| 2026-02-17 | Mesick Ralph | officer | Withheld for tax | 548 | 4,542 | Form 4 |
| 2026-02-17 | Matsumoto Dayna N | officer | Withheld for tax | 340 | 712 | Form 4 |
| 2026-02-17 | Matsumoto Dayna N | officer | Withheld for tax | 328 | 2,720 | Form 4 |
| 2026-02-17 | Matsumoto Dayna N | officer | Withheld for tax | 161 | 837 | Form 4 |
| 2026-02-17 | Matsumoto Dayna N | officer | Withheld for tax | 114 | 237 | Form 4 |
| 2026-02-17 | Martines Arnold D | officer | Award / grant | 11,635 | 11,635 | Form 4 |
| 2026-02-17 | Matsumoto Dayna N | officer | Award / grant | 2,974 | 2,974 | Form 4 |
| 2026-02-17 | Mesick Ralph | officer | Award / grant | 4,528 | 4,528 | Form 4 |
| 2026-02-17 | Morimoto David | officer | Award / grant | 5,898 | 5,898 | Form 4 |
| 2026-02-17 | Morimoto David | officer | Award / grant | 7,746 | 7,746 | Form 4 |
| 2026-02-17 | Martines Arnold D | officer | Award / grant | 13,384 | 13,384 | Form 4 |
| 2026-02-17 | Matsumoto Dayna N | officer | Award / grant | 1,052 | 1,052 | Form 4 |
| 2025-09-03 | Ngo Agnes Catherine | director | Gift | 1,612 | 63,847 | Form 4 |
| 2025-07-31 | Martines Arnold D | officer | Gift | 4,000 | 1,335 | Form 4 |
| 2025-05-15 | Rose Crystal | director | Award / grant | 2,807 | 15,025 | Form 4 |
| 2025-05-15 | Kindred Jonathan B | director | Award / grant | 2,717 | 13,950 | Form 4 |
| 2025-05-15 | Ota Saedene K | director | Award / grant | 2,581 | 13,814 | Form 4 |
| 2025-05-15 | FRY EARL E | director | Award / grant | 2,581 | 10,882 | Form 4 |
| 2025-05-15 | KOSASA PAUL | director | Award / grant | 2,536 | 72,712 | Form 4 |
| 2025-05-15 | Ngo Agnes Catherine | director | Award / grant | 2,536 | 75,458 | Form 4 |
| 2025-05-15 | Lutes Christopher | director | Award / grant | 2,264 | 21,604 | Form 4 |
| 2025-05-15 | Nobriga Robert | director | Award / grant | 2,264 | 6,277 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.